fainting on glp 1 GLP-1 Drugs Linked to Dizziness and Episodes GLP-1s tied to elevated risk

The obesity epidemic is a pressing public health challenge, with significant economic and societal costs

Wegovy tablets are approved at 1.5, 4, 9 and 25 mg with a 25 mg maintenance dosage for weight reduction and cardiovascular risk reduction

But these are anecdotal observations, not clinical evidence, and they shouldnt be taken as a basis for changing treatment without medical guidance. Alcohol and other substance use disorders are common, but they remain substantially underdiagnosed and undertreated

Pregnancy Safety Registries: Ongoing pharmacovigilance and pregnancy exposure registries are necessary to define teratogenic risk and optimal discontinuation intervals

In the six months following approval (JanuaryJune 2025), new starts increased by 16% among OSA patients

Aim for 25-40 grams of protein per meal